Bausch & Lomb Corp Increase (Decrease) in Accounts Payable and Accrued Liabilities
Bausch & Lomb Corp (BLCO) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $1.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-07-29
- Bausch & Lomb Corp increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $95.00M, a 2.06% decline year-over-year.
- Bausch & Lomb Corp increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$94.00M.
- Bausch & Lomb Corp increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was -$2.00M.
- Bausch & Lomb Corp increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $36.00M, a 61.70% decline year-over-year.
- Bausch & Lomb Corp increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $108.00M, a 14.29% decline from fiscal 2024.
- Bausch & Lomb Corp increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $126.00M, a 48.57% decline from fiscal 2023.
- Bausch & Lomb Corp increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $245.00M, a 29.63% increase from fiscal 2022.
- Bausch & Lomb Corp increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $189.00M, a 15.95% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $95.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $1.00M 10-Q · filed 2026-07-29 | -$1.00M derived: sum of 3 quarters · filed 2026-07-29 | $35.00M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | -$94.00M 10-Q · filed 2026-04-29 | -$96.00M derived: sum of 2 quarters · filed 2026-04-29 | -$60.00M derived: sum of 3 quarters · filed 2026-04-29 | $37.00M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $34.00M derived: sum of 2 quarters · filed 2026-02-18 | $131.00M derived: sum of 3 quarters · filed 2026-07-29 | $108.00M 10-K · filed 2026-02-18 |
| 2025-09-30 | $36.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $133.00M derived: sum of 2 quarters · filed 2026-07-29 | $110.00M 10-Q · filed 2025-10-29 | $3.00M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $97.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $74.00M 10-Q · filed 2026-07-29 | -$33.00M derived: sum of 3 quarters · filed 2026-07-29 | $61.00M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | -$23.00M 10-Q · filed 2026-04-29 | -$130.00M derived: sum of 2 quarters · filed 2026-04-29 | -$36.00M derived: sum of 3 quarters · filed 2026-04-29 | $33.00M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | -$107.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | -$13.00M derived: sum of 2 quarters · filed 2026-02-18 | $56.00M derived: sum of 3 quarters · filed 2026-02-18 | $126.00M 10-K · filed 2026-02-18 |
| 2024-09-30 | $94.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $163.00M derived: sum of 2 quarters · filed 2025-10-29 | $233.00M 10-Q · filed 2025-10-29 | $421.00M derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-06-30 | $69.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $139.00M 10-Q · filed 2025-07-30 | $327.00M derived: sum of 3 quarters · filed 2026-02-18 | $381.00M derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-03-31 | $70.00M 10-Q · filed 2025-04-30 | $258.00M derived: sum of 2 quarters · filed 2026-02-18 | $312.00M derived: sum of 3 quarters · filed 2026-02-18 | $333.00M derived: sum of 4 quarters · filed 2026-02-18 |
| 2023-12-31 | $188.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $242.00M derived: sum of 2 quarters · filed 2026-02-18 | $263.00M derived: sum of 3 quarters · filed 2026-02-18 | $245.00M 10-K · filed 2026-02-18 |
| 2023-09-30 | $54.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $75.00M derived: sum of 2 quarters · filed 2024-10-30 | $57.00M 10-Q · filed 2024-10-30 | $167.00M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-06-30 | $21.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $3.00M 10-Q · filed 2024-08-01 | $113.00M derived: sum of 3 quarters · filed 2025-02-19 | $114.00M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-03-31 | -$18.00M 10-Q · filed 2024-05-01 | $92.00M derived: sum of 2 quarters · filed 2025-02-19 | $93.00M derived: sum of 3 quarters · filed 2025-02-19 | $163.00M derived: sum of 4 quarters · filed 2025-02-19 |
| 2022-12-31 | $110.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $111.00M derived: sum of 2 quarters · filed 2025-02-19 | $181.00M derived: sum of 3 quarters · filed 2025-02-19 | $189.00M 10-K · filed 2025-02-19 |
| 2022-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $71.00M derived: sum of 2 quarters · filed 2023-11-01 | $79.00M 10-Q · filed 2023-11-01 | $2.00M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $70.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $78.00M 10-Q · filed 2023-08-02 | $1.00M derived: sum of 3 quarters · filed 2024-02-21 | $91.00M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $8.00M 10-Q · filed 2023-05-03 | -$69.00M derived: sum of 2 quarters · filed 2024-02-21 | $21.00M derived: sum of 3 quarters · filed 2024-02-21 | $174.00M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | -$77.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $13.00M derived: sum of 2 quarters · filed 2024-02-21 | $166.00M derived: sum of 3 quarters · filed 2024-02-21 | $163.00M 10-K · filed 2024-02-21 |
| 2021-09-30 | $90.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $243.00M derived: sum of 2 quarters · filed 2022-11-02 | $240.00M 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $153.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $150.00M 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | -$3.00M 10-Q · filed 2022-06-08 | |||
| 2020-12-31 | -$144.00M 10-K · filed 2023-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B |